SIMI, LISA
SIMI, LISA
Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer.
2009 Francesca Malentacchi; Lisa Simi; Caterina Nannelli; Matteo Andreani; Alberto Janni; Silvia Pastorekova; Claudio Orlando
An Italian Program of External Quality Control for Quantitative Assays Based on Real-Time PCR with Taq-Man Probes.
2005 C CASINI RAGGI; P VERDERIO; M PAZZAGLI; E MARUBINI; L SIMI; P PINZANI; A PARADISO; C. ORLANDO
Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells
2006 CELLAI I; BENVENUTI S; LUCIANI P; GALLI A; CENI E; SIMI L; BAGLIONI S; MURATORI M; OTTANELLI B; M. SERIO; THIELE CJ; PERI A
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer.
2011 Nicola Pratesi; Monica Mangoni; Irene Mancini; Fabiola Paiar; Lisa Simi; Lorenzo Livi; Sara Cassani; Michela Buglione; Salvatore Grisanti; Camillo Almici; Caterina Polli; Calogero Saieva; Stefano Maria Magrini; Giampaolo Biti; Mario Pazzagli; Claudio Orlando
Atypical Spitzoid melanocytic tumors: a morphological,mutational, and FISH analysis
2011 Massi D; Cesinaro AM; Tomasini C; Paglierani M; Bettelli S; Dal Maso L; Simi L; Salvianti F; Pinzani P; Orlando C; De Giorgi V; Lukic S; Maiorana A; Santucci M; Canzonieri V.
BRAFV600E detection in melanoma is highlyimproved by COLD-PCR.
2011 Pinzani P; Santucci C; Mancini I; Simi L; Salvianti F; Pratesi N; Massi D; De Giorgi V; Pazzagli M; Orlando C
Clodronate acts on human osteoclastic cell proliferation, differentiation and function in a bioreversible manner
2007 R. RECENTI; G. LEONE; L. SIMI; M. ORFEI; P. PINZANI; G. PIERACCINI; G. MONETI; CAROSSINO A.M.; A. FRANCHI; BARTOLUCCI G; CARBONELL SALA S; GINANNESCHI M. ; TANINI A.; BRANDI M.L
Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status.
2004 CIOPPI F.; SIMI L.; LUCIANI P.; PETRAGLIA F.; SUSINI T.; COBELLIS L.; SERIO M.; M. MAGGI; PERI A.
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors.
2015 Tassi, R; Perrone, G; Brugia, M; Simi, L; Petreni, P; Mori, E; Landini, I; Pazzagli, M; Mazzei, T; Mini, E; Nobili, S
From clinical trials to clinical practice: predictors ofresponse to erlotinib in advanced non-small cell lung cancer patients pretreated with chemotherapy
2011 Mazzoni F; Rotella V; Pratesi N; Boni L; Simi L; Orlando C; Comin CE; Maddau C; Di Costanzo F
Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers
2011 Vinci, Serena; Gelmini, Stefania; Pratesi, Nicola; Conti, Simona; Malentacchi, Francesca; Simi, Lisa; Pazzagli, Mario; Orlando, Claudio
Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers.
2011 Vinci S; Gelmini S; Pratesi N; Conti S; Malentacchi F; Simi L; Pazzagli M; Orlando C.
GM1 gangliosidosis: molecular analysis of nine patients and development of an RT-PCR assay for GLB1 gene expression profiling.
2007 Caciotti A; Donati MA; Procopio E; Filocamo M; Kleijer W; Wuyts W; Blaumeiser B; d'Azzo A; Simi L; Orlando C; McKenzie F; Fiumara A; Zammarchi E; Morrone A.
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer.
2008 Lisa Simi; Nicola Pratesi; Marina Vignoli; Roberta Sestini; Fabio Cianchi; Rosa Valanzano; Stefania Nobili; Enrico Mini; Mario Pazzagli; Claudio Orlando
Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.
2017 Righi, Alberto; Mancini, Irene; Gambarotti, Marco; Picci, Piero; Gamberi, Gabriella; Marraccini, Cristina; Dei Tos, Angelo Paolo; Simi, Lisa; Pinzani, Pamela; Franchi, Alessandro*
Implementation of a companion diagnostic in the clinical laboratory: The BRAF example in melanoma
2015 Mancini, Irene; Pinzani, Pamela; Simi, Lisa; Brandslund, Ivan; Vermeersch, Pieter; Di Resta, Chiara; Schwab, Matthias; Marc, Janja; van Schaik, Ron; Pazzagli, Mario
Influence of 17q gain and promoter polymorphisms on mRNA expression of somatostatin receptor type 2 in neuroblastoma.
2007 Lisa Simi; Pamela Pinzani; Claudia Casini Raggi; Mario Pazzagli; Claudio Orlando
Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
2006 Pamela Pinzani; Benedetta Salvadori; Lisa Simi; Simonetta Bianchi; Vito Distante; Luigi Cataliotti; Mario Pazzagli; Claudio Orlando
Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue
2004 C. ORLANDO; C. RAGGI C; S. BIANCHI; V. DISTANTE; L. SIMI; V. VEZZOSI; S. GELMINI; P. PINZANI; M. SMITH CAMERON; A. BUONAMANO; E. LAZZERI; M. PAZZAGLI; L. CATALIOTTI; M. MAGGI; M. SERIO
Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI.
2008 Nicola Fiotti; Nicola Altamura; Claudio Orlando; Lisa Simi; Bernhard Reimers; Pietro Pascotto; Bartolo Zingone; Andrea Pascotto; Mario Serio; Gianfranco Guarnieri; Carlo Giansante
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer. | 2009 | Francesca Malentacchi; Lisa Simi; Caterina Nannelli; Matteo Andreani; Alberto Janni; Silvia Pastorekova; Claudio Orlando | |
| An Italian Program of External Quality Control for Quantitative Assays Based on Real-Time PCR with Taq-Man Probes. | 2005 | C CASINI RAGGI; P VERDERIO; M PAZZAGLI; E MARUBINI; L SIMI; P PINZANI; A PARADISO; C. ORLANDO | |
| Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells | 2006 | CELLAI I; BENVENUTI S; LUCIANI P; GALLI A; CENI E; SIMI L; BAGLIONI S; MURATORI M; OTTANELLI B; M. SERIO; THIELE CJ; PERI A | |
| Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. | 2011 | Nicola Pratesi; Monica Mangoni; Irene Mancini; Fabiola Paiar; Lisa Simi; Lorenzo Livi; Sara Cassani; Michela Buglione; Salvatore Grisanti; Camillo Almici; Caterina Polli; Calogero Saieva; Stefano Maria Magrini; Giampaolo Biti; Mario Pazzagli; Claudio Orlando | |
| Atypical Spitzoid melanocytic tumors: a morphological,mutational, and FISH analysis | 2011 | Massi D; Cesinaro AM; Tomasini C; Paglierani M; Bettelli S; Dal Maso L; Simi L; Salvianti F; Pinzani P; Orlando C; De Giorgi V; Lukic S; Maiorana A; Santucci M; Canzonieri V. | |
| BRAFV600E detection in melanoma is highlyimproved by COLD-PCR. | 2011 | Pinzani P; Santucci C; Mancini I; Simi L; Salvianti F; Pratesi N; Massi D; De Giorgi V; Pazzagli M; Orlando C | |
| Clodronate acts on human osteoclastic cell proliferation, differentiation and function in a bioreversible manner | 2007 | R. RECENTI; G. LEONE; L. SIMI; M. ORFEI; P. PINZANI; G. PIERACCINI; G. MONETI; CAROSSINO A.M.; A. FRANCHI; BARTOLUCCI G; CARBONELL SALA S; GINANNESCHI M. ; TANINI A.; BRANDI M.L | |
| Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status. | 2004 | CIOPPI F.; SIMI L.; LUCIANI P.; PETRAGLIA F.; SUSINI T.; COBELLIS L.; SERIO M.; M. MAGGI; PERI A. | |
| Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. | 2015 | Tassi, R; Perrone, G; Brugia, M; Simi, L; Petreni, P; Mori, E; Landini, I; Pazzagli, M; Mazzei, T; Mini, E; Nobili, S | |
| From clinical trials to clinical practice: predictors ofresponse to erlotinib in advanced non-small cell lung cancer patients pretreated with chemotherapy | 2011 | Mazzoni F; Rotella V; Pratesi N; Boni L; Simi L; Orlando C; Comin CE; Maddau C; Di Costanzo F | |
| Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers | 2011 | Vinci, Serena; Gelmini, Stefania; Pratesi, Nicola; Conti, Simona; Malentacchi, Francesca; Simi, Lisa; Pazzagli, Mario; Orlando, Claudio | |
| Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. | 2011 | Vinci S; Gelmini S; Pratesi N; Conti S; Malentacchi F; Simi L; Pazzagli M; Orlando C. | |
| GM1 gangliosidosis: molecular analysis of nine patients and development of an RT-PCR assay for GLB1 gene expression profiling. | 2007 | Caciotti A; Donati MA; Procopio E; Filocamo M; Kleijer W; Wuyts W; Blaumeiser B; d'Azzo A; Simi L; Orlando C; McKenzie F; Fiumara A; Zammarchi E; Morrone A. | |
| High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer. | 2008 | Lisa Simi; Nicola Pratesi; Marina Vignoli; Roberta Sestini; Fabio Cianchi; Rosa Valanzano; Stefania Nobili; Enrico Mini; Mario Pazzagli; Claudio Orlando | |
| Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone. | 2017 | Righi, Alberto; Mancini, Irene; Gambarotti, Marco; Picci, Piero; Gamberi, Gabriella; Marraccini, Cristina; Dei Tos, Angelo Paolo; Simi, Lisa; Pinzani, Pamela; Franchi, Alessandro* | |
| Implementation of a companion diagnostic in the clinical laboratory: The BRAF example in melanoma | 2015 | Mancini, Irene; Pinzani, Pamela; Simi, Lisa; Brandslund, Ivan; Vermeersch, Pieter; Di Resta, Chiara; Schwab, Matthias; Marc, Janja; van Schaik, Ron; Pazzagli, Mario | |
| Influence of 17q gain and promoter polymorphisms on mRNA expression of somatostatin receptor type 2 in neuroblastoma. | 2007 | Lisa Simi; Pamela Pinzani; Claudia Casini Raggi; Mario Pazzagli; Claudio Orlando | |
| Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. | 2006 | Pamela Pinzani; Benedetta Salvadori; Lisa Simi; Simonetta Bianchi; Vito Distante; Luigi Cataliotti; Mario Pazzagli; Claudio Orlando | |
| Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue | 2004 | C. ORLANDO; C. RAGGI C; S. BIANCHI; V. DISTANTE; L. SIMI; V. VEZZOSI; S. GELMINI; P. PINZANI; M. SMITH CAMERON; A. BUONAMANO; E. LAZZERI; M. PAZZAGLI; L. CATALIOTTI; M. MAGGI; M. SERIO | |
| Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI. | 2008 | Nicola Fiotti; Nicola Altamura; Claudio Orlando; Lisa Simi; Bernhard Reimers; Pietro Pascotto; Bartolo Zingone; Andrea Pascotto; Mario Serio; Gianfranco Guarnieri; Carlo Giansante |